Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

China Approves AstraZeneca, Sanofi Shot to Prevent RSV Infection Beyfortus won’t be available in China until next season China’s RSV market projected to hit $1.5 billion by 2030 ...

Cases of human metapneumovirus, or HMPV, a contagious virus that can lead to respiratory disease, is reportedly spiking in northern China. Infectious disease experts say risk to the U.S. is low.

Moderna (NASDAQ:MRNA), the only company to market a messenger RNA-based vaccine against the respiratory syncytial virus (RSV), will soon face competition from China as regulators in the country ...

A wave of severe respiratory illnesses is sweeping China, causing havoc at hospitals in Beijing and other city in the north, ... RSV, influenza and common cold viruses.

China's National Medical Products Administration has given regulatory clearance for CSPC Pharmaceutical Group's respiratory syncytial virus (RSV) vaccine candidate to begin human clinical trials ...

So when the recent outbreak in northern China was met with widespread alarm, Williams allowed himself a wry smile. The forgotten burden of public health was finally being taken seriously.

As China continues to monitor an increase in cases of human metapneumovirus ... MORE: Cases of RSV, flu ticking up among young children in US as respiratory virus season begins ...

As China experiences a rise in respiratory infections this winter, ... “It will present in the same way as flu, sars-cov-2, RSV, so the same advice applies for those affected ...

Mild cases of HMPV usually last a few days to a week, and many people recover by themselves within two to five days. “It will present in the same way as flu, sars-cov-2, RSV, so the same advice ...